H1 2025 sales July 24, 2025 CONTENTS Q2 2025 highlights H1 2025 highlights H1 2025 activity by brand H1 2025 activity by region H1 2025 income H2 2025 launches 2025 outlook Questions & Answers 2 Q2 2025 highlights Philippe Benacin 3 Context Q2 2025 A wait-and-see attitude in many markets given the economic and geopolitical uncertainties But a US market that remained robust during the quarter • +6.8% (1) With solid performance by Interparfums • +8.4% (1) • Driven mainly by Jimmy Choo fragrances: +16% (1) (1) ...

2025 Second Quarter Conference Call Scheduled for August 6, 2025NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced net sales for three and six months ended June 30, 2025. Net Sales ($ in millions)Three Months EndedSix Months EndedJune 30,June 30, 2025 2024 < ...

Science, smells and secrecy. Get a whiff of the four giants that dominate the business of turning raw materials into flavours and fragrances https://t.co/Nm2zqikCiL ...

Core Insights - International Flavors & Fragrance (IFF) is a global leader in the creation of flavors and fragrances, distinguished by its proactive research approach in product development [1] Company Overview - IFF operates across multiple segments, focusing on long-term and medium-term value creation [1] Investment Focus - The company targets investments in firms with strong fundamentals, indicating a sector-agnostic investment strategy [1]

Core Insights - International Flavors & Fragrances Inc. (IFF) reported better-than-expected earnings for Q1, with earnings of $1.20 per share, surpassing the analyst consensus estimate of $1.14 per share [1] - The company achieved quarterly sales of $2.84 billion, exceeding the analyst consensus estimate of $2.83 billion [1] - CEO Erik Fyrwald highlighted disciplined execution and broad-based growth as key drivers of performance, along with successful divestiture of the Pharma Solutions business [2] Financial Performance - IFF's Q1 earnings per share were $1.20, beating expectations [1] - Quarterly sales reached $2.84 billion, also above analyst estimates [1] - The company affirmed its FY2025 sales guidance of $10.60 billion to $10.90 billion, compared to market estimates of $10.87 billion [2] Market Reaction - Following the earnings announcement, IFF shares dipped 7.1% to close at $73.59 [3] - Analysts adjusted their price targets for IFF after the earnings report [3] Analyst Ratings - Barclays analyst upgraded IFF from Equal-Weight to Overweight, raising the price target from $76 to $84 [8] - Baird analyst maintained an Outperform rating but lowered the price target from $110 to $100 [8]

Core Insights - Interparfums, Inc. (IPAR) reported first-quarter 2025 results with earnings of $1.32 per share, a 4% increase from $1.27 in the prior year, surpassing the Zacks Consensus Estimate of $1.13 per share [3] - Consolidated net sales reached $339 million, up 5% from $324 million year-over-year, with a 7% organic growth driven by strong performance in key fragrance brands [3][4] - The company reaffirmed its 2025 guidance, projecting net sales of $1.51 billion and earnings per share of $5.35, both reflecting a 4% year-over-year increase [13] Financial Performance - The gross margin improved to 63.7%, a 120-basis point increase from 62.5% in the prior year, attributed to a favorable brand and channel mix [6] - Operating income rose 10% to $75 million, with the operating margin expanding to 22.2%, up from 21% in the previous year [10] - Selling, general and administrative (SG&A) expenses were 41.6% of net sales, a slight increase of 10 basis points year-over-year, driven by higher advertising and promotional spending [7] Regional Sales Performance - North America and Western Europe saw sales increases of 14% and 1%, respectively, while Eastern Europe rebounded with a 46% rise in sales [4] - Sales in the Asia/Pacific region declined by 3%, Central and South America decreased by 10%, and the Middle East and Africa experienced a 16% decline, largely due to macroeconomic challenges and the exit from the Dunhill license [5] Inventory and Supply Chain Management - IPAR maintained steady inventory levels while accelerating raw material conversion to finished goods in anticipation of potential supply chain constraints [2] - The company is realigning its supply chain with key markets and exploring alternative sourcing outside China, planning selective price increases of 4% to 6% in August 2025 to offset recent tariffs [2] Financial Health - At the end of the quarter, IPAR had cash and cash equivalents of $96.6 million, long-term debt of $107.4 million, and total equity of $1,007.5 million [12] - The company announced a cash dividend of 80 cents per share, payable on June 30, 2025 [12]

Group 1 - Zacks Premium offers various tools for investors to enhance their stock market strategies, including daily updates, research reports, and stock screens [1] - The Zacks Style Scores are designed to help investors select stocks with the highest potential to outperform the market within a 30-day timeframe, rated from A to F based on value, growth, and momentum [2][9] - The Value Score focuses on identifying undervalued stocks using financial ratios like P/E and Price/Sales to find attractive investment opportunities [3] - The Growth Score emphasizes a company's financial health and future growth potential, analyzing projected and historical earnings and cash flow [4] - The Momentum Score assists investors in capitalizing on price trends, utilizing factors like recent price changes and earnings estimate shifts [5] - The VGM Score combines the three Style Scores to identify stocks with the best overall value, growth, and momentum characteristics [6] Group 2 - The Zacks Rank is a proprietary model that uses earnings estimate revisions to simplify stock selection, with 1 (Strong Buy) stocks achieving an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [7][8] - Investors are encouraged to select stocks with a Zacks Rank of 1 or 2 that also possess Style Scores of A or B to maximize potential returns [9][10] - Interparfums, Inc. (IPAR) is highlighted as a company to watch, currently rated 3 (Hold) with a VGM Score of B, and a Growth Style Score of A, indicating a forecasted earnings growth of 3.1% for the current fiscal year [11][12]

Financial Data and Key Metrics Changes - IFF generated approximately $2.8 billion in sales for Q1 2025, representing a 3% comparable currency neutral growth [10] - Adjusted operating EBITDA totaled $578 million for the quarter, a strong 9% increase on a comparable currency neutral basis [10] - Comparable currency neutral adjusted operating EBITDA margin increased more than 120 basis points to 20.3% [10] Business Line Data and Key Metrics Changes - Pharma Solutions delivered $266 million in sales, an 8% year-over-year increase on a comparable currency neutral basis [11] - Taste segment sales were $627 million, a 7% year-over-year increase on a comparable currency neutral basis [13] - Food Ingredients had sales of $796 million, a 4% comparable currency neutral decrease from the prior year [13] - Health and Biosciences segment delivered a 5% increase in comparable currency neutral sales [14] - Scent achieved net sales of $614 million, up 4% year-over-year on a comparable currency neutral basis [14] Market Data and Key Metrics Changes - The company noted that broader macroeconomic dynamics remain challenging, but IFF's portfolio is grounded in resilient essential end markets [20] - The company expects approximately 2% adverse impact on revenue from foreign exchange, down from 4% previously [22] Company Strategy and Development Direction - IFF is focused on strengthening its business through consistent reinvestment in core growth drivers: R&D, commercial, digital, and capacity [20] - The company is maintaining its full-year guidance ranges despite macroeconomic uncertainties [21] - IFF completed the divestiture of Pharma Solutions, which strengthens its capital structure and helps achieve a net debt to credit adjusted EBITDA ratio of below three times [7][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the order book remaining consistent with guidance despite macroeconomic uncertainties [28] - The company is actively working with customers to mitigate impacts of tariff actions and remains disciplined in response to macroeconomic uncertainty [9] - Management acknowledged concerns about potential recessionary pressures but emphasized the resilience of 80% of its portfolio in essential products [29] Other Important Information - Cash flow from operations totaled $127 million year-to-date, with CapEx at $179 million, approximately 6% of sales [15] - Gross debt was approximately $9.3 billion, a decrease of more than $1 billion compared to the year-ago period [17] Q&A Session All Questions and Answers Question: Can you talk us through which areas of the portfolio could potentially be at risk and which parts could be more resilient in a recessionary scenario? - Management indicated that 80% of the portfolio is in essential products, which are resilient, while discretionary areas like fine fragrances may be at risk [29] Question: Can you disclose what you think the gross impact today is on your costs from tariffs? - Management noted a gross exposure of over $100 million for 2025 related to tariffs, primarily from China, but emphasized successful supply chain optimization efforts [35] Question: What were the year-ago comps for flavors and food ingredients? - Management reported that Taste grew 11% last year in Q1, while Food Ingredients declined 4% last year [40] Question: Can you elaborate on the strategic rationale for the joint venture with Chimera? - The joint venture aims to scale enzymatic biomaterials and is expected to start operations by the end of 2027, targeting high-value biodegradable polymers [44][46] Question: What drove volumes lower in protein solutions? - Management indicated that volumes were down due to weaker performance in lower-value areas and production issues in higher-value areas, which are being resolved [55] Question: How do you see the inventory cycle affecting IFF? - Management expressed that they do not believe inventory levels are elevated enough to cause a significant downtick, given the recent destocking period [88]

For the quarter ended March 2025, International Flavors (IFF) reported revenue of $2.84 billion, down 1.9% over the same period last year. EPS came in at $1.20, compared to $1.13 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $2.83 billion, representing a surprise of +0.29%. The company delivered an EPS surprise of +7.14%, with the consensus EPS estimate being $1.12. View all Key Company Metrics for International Flavors here>>> Shares of International Flavors have ...

Inter Parfums (IPAR) Q1 2025 Earnings Call May 06, 2025 11:00 AM ET Company Participants Karin Daly - Investor RelationsJean Madar - Chairman, CEO & Co-FounderMichel Atwood - CFOAshley Helgans - Senior Vice PresidentHamed Khorsand - Principal Conference Call Participants Susan Anderson - Managing Director & Senior AnalystKorinne Wolfmeyer - Vice President & Senior Equity Research Analyst - Beauty and WellnessLuca Codagnone - Analyst Operator Greetings, and welcome to the Interperform's First Quarter twenty ...